Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 3/20 | 0.60 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.59 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.59 |
| ▸ | SLC18A2 | Q05940 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | ACACB | O00763 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | LDHA | P00338 | 1/20 | 0.52 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL178622 | 1.00 | SLC6A4 (0.60) | SLC6A4TAAR1SIGMAR1SLC18A2L3MBTL1 | |
| Hydrochloric Acid SCHEMBL29410112 | 0.98 | SLC6A4 (0.58) | SLC6A4TAAR1SIGMAR1SLC18A2L3MBTL1 | |
| SCHEMBL24105648 | 0.84 | SLC6A4 (0.66) | SLC6A4SIGMAR1L3MBTL1MEN1KMT2A | |
| SCHEMBL25890567 | 0.84 | SLC6A4 (0.66) | SLC6A4SIGMAR1L3MBTL1MEN1KMT2A | |
| SCHEMBL4380664 | 0.83 | TAAR1 (0.49) | SLC6A4TAAR1SIGMAR1SLC18A2MEN1 | |
| SCHEMBL10395444 | 0.82 | SLC6A4 (0.63) | SLC6A4SIGMAR1L3MBTL1MEN1KMT2A | |
| SCHEMBL2958349 | 0.82 | SLC6A4 (0.58) | SLC6A4SIGMAR1L3MBTL1MEN1KMT2A | |
| SCHEMBL21089970 | 0.82 | CYP1A2 (0.61) | SLC6A4SIGMAR1L3MBTL1MEN1KMT2A | |
| SCHEMBL16383872 | 0.82 | SLC6A4 (0.58) | SLC6A4SIGMAR1L3MBTL1MEN1KMT2A | |
| SCHEMBL3341789 | 0.81 | SIGMAR1 (0.61) | SLC6A4SIGMAR1L3MBTL1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250130211-A1 | METHOD OF SCREENING NEW PSYCHOACTIVE SUBSTANCE AND PLATFORM THEREOF | NATIONAL TAIWAN UNIVERSITY (TW) | 2025-04-24 | — | — | US | claimed |
| US-9435816-B2 | Deuterium free, stable isotope labeled 2-phenylethylamine hallucinogens and/or stimulants, methods of their preparation and their use | CHIRON AS (NO) | 2016-09-06 | — | — | US | claimed |
| US-20140227792-A1 | DEUTERIUM FREE, STABLE ISOTOPE LABELED 2-PHENYLETHYLAMINE HALLUCINOGENS AND/OR STIMULANTS, METHODS OF THEIR PREPARATION AND THEIR USE | CHIRON A/S (NO) | 2014-08-14 | — | — | US | claimed |
| WO-2013014287-A2 | DEUTERIUM FREE, STABLE ISOTOPE LABELED 2-PHENYLETHYLAMINE HALLUCINOGENS AND/OR STIMULANTS, METHODS OF THEIR PREPARATION AND THEIR USE | CHIRON AS (NO) | 2013-01-31 | — | — | WO | claimed |
| EP-2551675-A1 | Deuterium free, stable isotope labeled 2-phenylethylamine hallucinogens and/or stimulants, methods fo their preparation and their use | Chiron AS (NO) | 2013-01-30 | — | — | EP | claimed |
| US-20080157427-A1 | METHOD FOR FABRICATING MICRONEEDLE ARRAY AND METHOD FOR FABRICATING EMBOSSING MOLD OF MICRONEEDLE ARRAY | NATIONAL CHIAO TUNG UNIVERSITY (TW) | 2008-07-03 | — | — | US | claimed |
| EP-3841085-B1 | NBOME TEST | UNIV SYDNEY TECHNOLOGY (AU) | 2026-05-06 | — | — | EP | disclosed |
| US-12478995-B2 | Fluid dispensing systems | ROOFTOP RESEARCH, LLC (US) | 2025-11-25 | — | — | US | disclosed |
| US-12429484-B2 | Homogeneous enzyme immunoassay for keratinized structures | PSYCHEMEDICS CORPORATION (US) | 2025-09-30 | — | — | US | disclosed |
| US-12385919-B2 | — | — | 2025-08-12 | — | — | US | disclosed |
| US-20250177354-A1 | THERAPEUTIC COMBINATIONS, COMPOSITIONS, AND METHODS FOR DESIGNING AND PRODUCING ENTACTOGENIC MINDSTATES | MINDSTATE DESIGN LABS INC (US) | 2025-06-05 | — | — | US | disclosed |
| EP-3710837-B1 | CATHINONE TEST | UNIV SYDNEY TECHNOLOGY (AU) | 2025-05-07 | — | — | EP | disclosed |
| US-20250130211-A1 | METHOD OF SCREENING NEW PSYCHOACTIVE SUBSTANCE AND PLATFORM THEREOF | NATIONAL TAIWAN UNIVERSITY (TW) | 2025-04-24 | — | — | US | disclosed |
| WO-2007016190-A2 | ANTIPARKINSONIAN ACTION OF PHENYLISOPROPYLAMINES | DUKE UNIVERSITY (US) | 2007-02-08 | — | — | WO | disclosed |
| US-20070027208-A1 | Antiparkinsonian Action of Phenylisopropylamines | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-02-01 | — | — | US | disclosed |
| US-7166202-B2 | Medical diagnosis; analyzing using isoelectric point | PROTEIN FOREST, INC. (US) | 2007-01-23 | — | — | US | disclosed |
| US-20060046273-A1 | Homogeneous enzyme immunoassay for oral fluid | LIN-ZHI INTERNATIONAL INC. (US) | 2006-03-02 | — | — | US | disclosed |
| EP-1410029-A2 | ARRAYS OF BUFFERS FOR ANALYSING BIOMOLECULES BY THEIR ISOELECTRIC POINT | Protein, Forest, Inc. (US) | 2004-04-21 | — | — | EP | disclosed |
| US-20030102215-A1 | Matrixes, arrays, systems and methods | ProteinSimple | 2003-06-05 | — | — | US | disclosed |
| WO-2003008977-A2 | ARRAYS OF BUFFERS FOR ANALYSING BIOMOLECULES BY THEIR ISOELECTRIC POINT | PROTEIN, FOREST, INC. (US) | 2003-01-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140227792-A1 | DEUTERIUM FREE, STABLE ISOTOPE LABELED 2-PHENYLETHYLAMINE HALLUCINOGENS AND/OR STIMULANTS, METHODS OF THEIR PREPARATION AND THEIR USE | PNMT, HTR2C, HTR2A | SLC6A4 50/4885TAAR1 16/4885SIGMAR1 66/4885 |
| US-20070027208-A1 | Antiparkinsonian Action of Phenylisopropylamines | PNMT, SNCA, COMT | SLC6A4 178/4885TAAR1 1075/4885SIGMAR1 188/4885 |
| US-20250177354-A1 | THERAPEUTIC COMBINATIONS, COMPOSITIONS, AND METHODS FOR DESIGNING AND PRODUCING ENTACTOGENIC MINDSTATES | CNR2, CNR1, HTR6 | SLC6A4 84/4885TAAR1 232/4885SIGMAR1 1213/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.